Dr Emanuela Volpi
I am a Reader in the School of Life Sciences, College of Liberal Arts and Sciences. I was educated in Italy and hold a PhD in Evolutionary Biology (Molecular Biology and Genetics) from the University of Rome ‘La Sapienza’. Before joining Westminster, I worked as a Post-Doctoral Research Fellow at Cancer Research UK. I was subsequently appointed Head of Molecular Cytogenetics and Microscopy at the Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine (University of Oxford). My teaching and research expertise is in medical molecular genetics, specifically focusing on genome functional organisation, chromosomal fragility and instability, nuclear architecture and dynamics, and cancer biomarkers. My current research at Westminster is multidisciplinary and focuses on understanding the risks to human health in light of genome-environment interactions. Throughout my scientific career, I have published extensively in international, peer-reviewed journals, including high-profile academic outlets such as Science and Nature Communications. As the former PhD Coordinator for the School of Life Sciences and College of Liberal Arts and Sciences and acting Deputy Director of the Graduate School, and PhD supervisor and examiner, I have extensive experience in postgraduate research supervision and mentoring of early career researchers. My advisory roles include the Scientific Programme Committee of the European Cytogenomics Conference and Chair of the ‘Chromosome Stability, Integrity and Dynamics’ permanent working group of the European Cytogeneticists Association. I also have extensive editorial experience and was recently appointed by Springer as Editor in Chief of Molecular Cytogenetics. I am the Genetics Society UK Ambassador at Westminster, a Member of the British Society for Genetic Medicine, a Fellow of the Royal Society of Biology and a Fellow of the Higher Education Academy.
Genome health - defined as genome structural integrity and stability - is crucial for cellular and organismic fitness. My research applies molecular biology techniques and modern microscopy techniques for the assessment and monitoring of genome health from a chromosomal and nuclear architecture perspective, with the main aims of (1) understanding the requirements for genome health maintenance in vitro and in vivo, and (2) identifying pre-pathological biomarkers with translational potential.